http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3666765-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e02c5457922dff82195ed73b36302436 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-74 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-74 |
| filingDate | 2018-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e28c003cdf4e66d70e241dbc8afbaeb2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f34f2117acbf375cebc2e821763d331 |
| publicationDate | 2020-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-3666765-A1 |
| titleOfInvention | Chromenic phytocannabinoids, their synthesis and use in treatment or prevention of disease |
| abstract | The present invention relates to a compound of the formula (I) or a solvate or co-crystal thereofwherein:- R is selected from the group consisting of: a C<sub>1</sub>-C<sub>6</sub>alkyl, a C<sub>2</sub>-C<sub>8</sub>alkenyl moiety, a C<sub>4</sub>-C<sub>12</sub>dienyl or a C<sub>6</sub>-C18 trienyl moiety;- R<sub>1</sub>is a C<sub>1</sub>-C<sub>6</sub>alkyl moiety;- R<sub>2</sub>is selected from the group consisting of: H and a C<sub>1</sub>-C<sub>6</sub>alkyl moiety;- R<sub>3</sub>is selected from the group consisting of: H and a C<sub>1</sub>-C<sub>6</sub>alkyl moiety;- R<sub>4</sub>is selected from the group consisting of: H, a C<sub>1</sub>-C<sub>6</sub>alkyl moiety and a benzyl moiety. The present invention also relates to a process for producing said compound of the formula (I), or a solvate or co-crystal thereof, as well as a pharmaceutical composition comprising said compound of the formula (I), or a solvate or co-crystal thereof and at least one excipient. The present invention also relates to a compound of the formula (I), or a solvate or co-crystal thereof, for use in the treatment or prevention of a disease or condition. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021138610-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023114229-A1 |
| priorityDate | 2018-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 215.